Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04762199 |
Title | MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Emory University |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |